Funding Opportunity RFA-AG-24-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform initiative. This Platform aims to transform the AD/ADRD research enterprise by serving as a central hub of research access that aims to: 1) improve applicability and generalizability of findings through larger datasets that include more diverse populations; 2) capture more complete information through linking a variety of data sources; 3) increase the speed at which scientific questions can be answered; and 4) improve researchers ability to answer questions that cannot be feasibly or readily answered via clinical trial.

Negotiable: AstraZeneca : The Biologics Engineering team is responsible for the discovery and optimisation of next generation biological drug candidates for all key therapy ar Cambridgeshire, England

Notice NOT-MD-23-007 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-019 from the NIH Guide for Grants and Contracts

The expected annual base salary for this position is $300,000–$450,000. : D. E. Shaw Research: D. E. Shaw Research is seeking pre-clinical translational scientists with experience in drug discovery to join our New York–based team. New York City, New York (US)

Notice NOT-CA-23-048 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-127 from the NIH Guide for Grants and Contracts. The Office of Research Infrastructure Programs (ORIP) within the Division of Program Coordination, Planning, and Strategic Initiatives announces an opportunity to apply for small grant support for ORIP-supported Special Emphasis Research Career Award (SERCA) K01 recipients who have completed the first two years (24 months) of the SERCA K01 award. ORIP seeks to enhance the ability of ORIP SERCA K01 awardees to conduct research as they transition to fully independent investigator status. The R03 mechanism supports projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support research projects that can realistically be completed in two years and that require limited levels of funding. This Funding Opportunity Announcement does not accept applications proposing clinical trial(s).

Notice NOT-HL-23-068 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-069 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-24-008 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement (FOA) is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; developing junior scientists; and maximizing the efficiency of research support.

Funding Opportunity PAR-23-125 from the NIH Guide for Grants and Contracts. Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly innovative studies that address NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The nexus with drug abuse should be clearly described. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches, both basic and clinical, which have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately, eradicating HIV.

Negotiable: Wellcome Sanger Institute: Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity's greatest challenges. Homeworking

Funding Opportunity RFA-AG-24-012 from the NIH Guide for Grants and Contracts. It is essential to expand and diversify the skilled Alzheimers Disease and Alzheimers Disease and Related Dementias (AD/ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their career exploration. This Funding Opportunity Announcement (FOA) supports the development and implemention of research education programs for recent baccalaureates from diverse backgrounds.

Funding Opportunity RFA-AG-24-013 from the NIH Guide for Grants and Contracts. It is essential to expand and diversify the skilled Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their career exploration. This Funding Opportunity Announcement (FOA) supports the development and implementation of summer research education programs for high school students, undergraduates, or science teachers from diverse backgrounds.

Funding Opportunity RFA-CA-23-025 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to support the development and testing of primary care practice- and health system-level interventions and strategies to promote high quality care for adult cancer survivors during and/or after cancer treatment.

Funding Opportunity PAR-23-117 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

Funding Opportunity RFA-OD-23-013 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Womens Health (ORWH) and the scientific partnering Institutes and Centers across NIH.

Funding Opportunity PAR-23-116 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

Notice NOT-ES-23-008 from the NIH Guide for Grants and Contracts

Notice NOT-TW-23-004 from the NIH Guide for Grants and Contracts